CNBC’s "Fast Money Halftime Report," Stephanie Link said she likes AbbVie Inc (NYSE: ABBV). The stock trades at 30% discount to its peers, it has a great immunology franchise and it has synergies from the Allergan purchase. With a yield of 5.2%, she thinks it’s a great quality stock for the long term.” data-reactid=”19″>On CNBC’s “Fast Money Halftime Report,” Stephanie Link said she likes AbbVie Inc (NYSE: ABBV). The stock trades at 30% discount to its peers, it has a great immunology franchise and it has synergies from the Allergan purchase. With a yield of 5.2%, she thinks it’s a great quality stock for the long term.
GOLD) and he is looking for more opportunities to buy it into the mid-$20s. He believes the company is going to be very profitable over the next couple of years, given how low energy prices are and how elevated both gold and copper have become.
JPM) on dips.
LOW). He would be a buyer on a pullback.
View Article Origin Here
